Related Experiment Videos
Safety of moclobemide in clinical use
1CKW Consulting, Verona, NJ.
Clinical Neuropharmacology
|January 1, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target.
British journal of anaesthesia·2019
Bulb of penis as a marker for prostatic apex in external beam radiotherapy of prostate cancer.
International journal of radiation oncology, biology, physics·2003
Rheological microscopy: local mechanical properties from microrheology.
Physical review letters·2003
Androgen regulation of the cell-cell adhesion molecule-1 (Ceacam1) gene.
Molecular and cellular endocrinology·2001
Characterization of Propranolol Use and Outcomes in Traumatic Brain Injury at a Level I Trauma Center.
Clinical neuropharmacology·2026
Review of Medications That Reduce Neurological Deficits in Patients With Traumatic Brain Injury.
Clinical neuropharmacology·2026
A Double-blind, Placebo-controlled Study of Lumateperone in the Treatment of Borderline Personality Disorder.
Clinical neuropharmacology·2026
Yesterday Once More: Revisiting Catatonia in an Elderly Stroke Patient.
Clinical neuropharmacology·2026
Overlapping Hyperosmolar Therapy in Patients With Elevated and Refractory Intracranial Pressure.
Clinical neuropharmacology·2026
MRI Proton Density Fat Fraction as a Biomarker of Marrow Recovery Following Organ-Sparing Total Marrow Irradiation in Sickle Cell Disease.
Journal of magnetic resonance imaging : JMRI·2026
Spinal Mucormycosis Following a Traditional Cupping Procedure in a Diabetic Patient: A Rare Case Report from Somalia.
International medical case reports journal·2026
Atypical MRI presentation of symmetrical thalamic and basal ganglia lesions in adult-onset MOG-IgG-associated disease: a case report.
Frontiers in human neuroscience·2026